Mongolian veterinary drug for resisting escherichia coli diarrhea and preparation method thereof
A technology of Escherichia coli and veterinary medicine, which is applied in the direction of antibacterial drugs, pharmaceutical formulas, and resistance to vector-borne diseases. Effects on survival and growth rate
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] Example 1: Optimization and screening experiment of Mongolian veterinary drug BBS traditional compound recipe
[0050] 1.1 Experimental consumables and equipment
[0051] 1.1.1 Main reagents
[0052] Ordinary nutrient agar, eosin methylene blue nutrient agar, nutrient broth, ciprofloxacin (batch number: 11220023), purchased from Guangzhou Baiyunshan Pharmaceutical Co., Ltd.; Yunxiang, rhubarb, Gansong, Qumai, etc. were all purchased from Inner Mongolia Tianli Pharmaceutical Co., Ltd.
[0053] 1.1.2 Strains
[0054] Pathogenic Escherichia coli (E.coli O 1) was presented by Professor Ao Ri Gele from the Cattle Production Laboratory of the School of Animal Science, Inner Mongolia Agricultural University. The strain was isolated, identified and preserved by Dr. Yang Siqin in the experimental team of Professor Ao Ri Gele.
[0055] 1.1.3 Experimental animals
[0056] SPF-grade Kunming mice, half male and half female, weighing 23±2g, were purchased from the Experimental A...
Embodiment 2
[0127] Example 2: Clinical cure experiment of Mongolian veterinary drug BBS on calves with Escherichia coli diarrhea
[0128] 2.1 Experimental materials
[0129] 2.1.1 Test animals
[0130] 48 Holstein calves with similar body weight (40±2kg) were selected. They were randomly divided into 6 groups with 8 heads in each group.
[0131] 2.1.2 Experimental drug
[0132] The 7 flavors of Mongolian medicine were pulverized with a pulverizer, passed through a 200-mesh sieve, and formulated according to the developed dosage, all of which were purchased from Inner Mongolia Tianli Pharmaceutical Co., Ltd. The ciprofloxacin group (production batch number: 20180316) was purchased from Chengdu Xinheng Pharmaceutical Co., Ltd.
[0133] 2.2 Test method
[0134] 2.2.1 Experimental design
[0135] Trials were conducted at the Knight Ranch in Dalat Banner, Ordos, Inner Mongolia, with permission from the company's owners. All experimental protocols have been approved by the Animal Care Co...
Embodiment 3
[0162] Example 3 Effect of Mongolian veterinary drug BBS compound on intestinal mucosal biological barrier in mice with Escherichia coli diarrhea
[0163] 3.1 Experimental materials
[0164] 3.1.1 Experimental bacteria
[0165] Pathogenic Escherichia coli (E.coli O 1 ) was presented by Professor Ao Rigele from the Cattle Production Laboratory of the School of Animal Science, Inner Mongolia Agricultural University, and was isolated, identified and preserved by Dr. Yang Siqin.
[0166] 3.1.2 Experimental animals
[0167] SPF-grade Kunming mice, half male and half female, weighing 23±2g, were purchased from the Experimental Animal Center of Inner Mongolia University, license number: SCXK (Mongolia 2016-0001). In a separate dry ventilated cage, 10 per cage, constant temperature (21±2°C), constant humidity (53±5%), free access to food and water, light / dark cycle of 12h. Adapt to feeding for 3 days and carry out experiments. Experiments were performed in accordance with protoco...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com